Leukine (Berlex Laboratories Inc)
Brand names,
Leukine (Berlex Laboratories Inc)
Analogs
Leukine (Berlex Laboratories Inc)
Brand Names Mixture
Leukine (Berlex Laboratories Inc)
Chemical_Formula
C639H1006N168O196S8
Leukine (Berlex Laboratories Inc)
RX_link
http://www.rxlist.com/cgi/generic/sargramostim.htm
Leukine (Berlex Laboratories Inc)
fda sheet
Leukine (Berlex Laboratories Inc)
msds (material safety sheet)
Leukine (Berlex Laboratories Inc)
Synthesis Reference
No information avaliable
Leukine (Berlex Laboratories Inc)
Molecular Weight
14434.5
Leukine (Berlex Laboratories Inc)
Melting Point
No information avaliable
Leukine (Berlex Laboratories Inc)
H2O Solubility
No information avaliable
Leukine (Berlex Laboratories Inc)
State
Liquid
Leukine (Berlex Laboratories Inc)
LogP
No information avaliable
Leukine (Berlex Laboratories Inc)
Dosage Forms
Solution (IV Infusion); Solution (Subcutaneous Injection)
Leukine (Berlex Laboratories Inc)
Indication
For the treatment of cancer and bone marrow transplant
Leukine (Berlex Laboratories Inc)
Pharmacology
Sargramostim is used in the treatment of bone marrow transplant recipients or those exposed to chemotherapy an recovering from acut myelogenous leukemia, Leukine or GM-CSF is a hematopoietic growth factor which stimulates the survival, clonal expansion (proliferation) and differentiation of hematopoietic progenitor cells. GM-CSF is also capable of activating mature granulocytes and macrophages. After a bone marrow transplant or chemotherapy, patients have a reduced capacity to produce red and white blood cells. Supplementing them with external sources of GM-CSF helps bring the level of neutrophils back to normal so that they can better fight infections.
Leukine (Berlex Laboratories Inc)
Absorption
No information avaliable
Leukine (Berlex Laboratories Inc)
side effects and Toxicity
No information avaliable
Leukine (Berlex Laboratories Inc)
Patient Information
No information avaliable
Leukine (Berlex Laboratories Inc)
Organisms Affected
No information avaliable